Cargando…

Drug use and harm reduction in Afghanistan

Opium has been cultivated in Afghanistan since 1100 A.D., although production has steadily increased since 1979. Currently, Afghanistan produces three-quarters of the global opium supply, with injection drug use and HIV currently following the opium trade route through Central Asia. Although systema...

Descripción completa

Detalles Bibliográficos
Autores principales: Todd, Catherine S, Safi, Naqibullah, Strathdee, Steffanie A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1262742/
https://www.ncbi.nlm.nih.gov/pubmed/16146577
http://dx.doi.org/10.1186/1477-7517-2-13
_version_ 1782125899865391104
author Todd, Catherine S
Safi, Naqibullah
Strathdee, Steffanie A
author_facet Todd, Catherine S
Safi, Naqibullah
Strathdee, Steffanie A
author_sort Todd, Catherine S
collection PubMed
description Opium has been cultivated in Afghanistan since 1100 A.D., although production has steadily increased since 1979. Currently, Afghanistan produces three-quarters of the global opium supply, with injection drug use and HIV currently following the opium trade route through Central Asia. Although systematic studies are lacking, heroin use appears to be on the rise in Afghanistan. The purpose of this paper is to briefly provide historical background and current statistics for drug production and use in Afghanistan, to discuss the new government's policies towards problem drug use and available rehabilitation programs, and to assess Afghan harm reduction needs with consideration of regional trends.
format Text
id pubmed-1262742
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-12627422005-10-22 Drug use and harm reduction in Afghanistan Todd, Catherine S Safi, Naqibullah Strathdee, Steffanie A Harm Reduct J Commentary Opium has been cultivated in Afghanistan since 1100 A.D., although production has steadily increased since 1979. Currently, Afghanistan produces three-quarters of the global opium supply, with injection drug use and HIV currently following the opium trade route through Central Asia. Although systematic studies are lacking, heroin use appears to be on the rise in Afghanistan. The purpose of this paper is to briefly provide historical background and current statistics for drug production and use in Afghanistan, to discuss the new government's policies towards problem drug use and available rehabilitation programs, and to assess Afghan harm reduction needs with consideration of regional trends. BioMed Central 2005-09-07 /pmc/articles/PMC1262742/ /pubmed/16146577 http://dx.doi.org/10.1186/1477-7517-2-13 Text en Copyright © 2005 Todd et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Todd, Catherine S
Safi, Naqibullah
Strathdee, Steffanie A
Drug use and harm reduction in Afghanistan
title Drug use and harm reduction in Afghanistan
title_full Drug use and harm reduction in Afghanistan
title_fullStr Drug use and harm reduction in Afghanistan
title_full_unstemmed Drug use and harm reduction in Afghanistan
title_short Drug use and harm reduction in Afghanistan
title_sort drug use and harm reduction in afghanistan
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1262742/
https://www.ncbi.nlm.nih.gov/pubmed/16146577
http://dx.doi.org/10.1186/1477-7517-2-13
work_keys_str_mv AT toddcatherines druguseandharmreductioninafghanistan
AT safinaqibullah druguseandharmreductioninafghanistan
AT strathdeesteffaniea druguseandharmreductioninafghanistan